← Leaderboards
Joanna E Burdette
University Of Illinois At Chicago
$8,615,329
Attributed
$15,087,802
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,087,802 · 11
By mechanism
R01$8,996,701 · 3
K12$3,585,311 · 1
R21$1,152,215 · 3
P01$1,132,943 · 2
R03$157,000 · 1
F31$63,632 · 1
Top collaborators
- Jonathan Coppeta8 shared
- Brian Thacher Murphy8 shared
- Laura Margaret Sanchez8 shared
- Larisa Nonn5 shared
- Thomas J. Meade2 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Guido F Pauli$8,225,012
- Brian Thacher Murphy$2,779,372
- Donna Elizabeth Webster$103,438
- Zaijie Jim Wang$13,634,711
- Norman R Farnsworth$4,328,955
Others in their field
Top investigators on “Biological”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologicalMalignant Neoplasm Of OvaryCellsProteinsIn VivoSignal TransductionMalignant NeoplasmsTumorResponsePathway InteractionsEpithelial CellsTissuesNeoplasm Metastasis3-DimensionalSourceXenograft ProcedurePreventMammalian OviductsSerousCollaborationsTechnologyMigrationMonitorEpithelium
Grant awards (45)
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer$592,455
R01 · FY2025 · CA · contact PI
Botanical derived progestins and their impact on women's health$359,775
R01 · FY2025 · AT · contact PI
Core 1: Biological Correlation and Analysis Core$213,429
P01 · FY2025 · CA · contact PI
IRACDA at University of Illinois at Chicago$859,797
K12 · FY2024 · GM
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer$622,570
R01 · FY2024 · CA · contact PI
Botanical derived progestins and their impact on women's health$391,755
R01 · FY2024 · AT · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$371,644
R01 · FY2024 · CA · contact PI
Core:1 Biological Testing$182,156
P01 · FY2024 · CA · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$40,632
R01 · FY2024 · CA · contact PI
IRACDA at University of Illinois at Chicago$859,797
K12 · FY2023 · GM
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer$527,572
R01 · FY2023 · CA · contact PI
Botanical derived progestins and their impact on women's health$399,750
R01 · FY2023 · AT · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$383,381
R01 · FY2023 · CA · contact PI
Core:1 Biological Testing$184,996
P01 · FY2023 · CA · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$79,176
R01 · FY2023 · CA · contact PI
IRACDA at University of Illinois at Chicago$859,797
K12 · FY2022 · GM
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer$528,019
R01 · FY2022 · CA · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$360,469
R01 · FY2022 · CA · contact PI
Core:1 Biological Testing$164,505
P01 · FY2022 · CA · contact PI
Development of quantitative mass spectrometry assays and imaging for cancer metastasis$85,846
R01 · FY2022 · CA · contact PI
IRACDA at University of Illinois at Chicago$621,239
K12 · FY2021 · GM
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer$538,813
R01 · FY2021 · CA · contact PI
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$376,650
R01 · FY2021 · CA · contact PI
Core:1 Biological Testing$191,747
P01 · FY2021 · CA · contact PI
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer$538,941
R01 · FY2020 · CA · contact PI
IRACDA at University of Illinois at Chicago$384,681
K12 · FY2020 · GM
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis$376,650
R01 · FY2020 · CA · contact PI
Botanical derived progestins and their impact on women's health$359,775
R01 · FY2020 · AT · contact PI
Core:1 Biological Testing$196,110
P01 · FY2020 · CA · contact PI
Microfluidic Models of Ovarian Cancer Preneoplastic Lesions$71,919
R01 · FY2020 · CA · contact PI
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer$551,809
R01 · FY2019 · CA · contact PI
Botanical derived progestins and their impact on women's health$359,775
R01 · FY2019 · AT · contact PI
Botanical derived progestins and their impact on women's health$359,775
R01 · FY2018 · AT · contact PI
Botanical derived progestins and their impact on women's health$359,775
R01 · FY2017 · AT · contact PI
Pax2 loss in fallopian tube lesions and strategies for restoration in serous cancer$163,017
R21 · FY2017 · CA · contact PI
Botanical derived progestins and their impact on women's health$359,775
R01 · FY2016 · AT · contact PI
Pax2 loss in fallopian tube lesions and strategies for restoration in serous cancer$196,475
R21 · FY2016 · CA · contact PI
Identification of novel phytoprogestins from hops and red clover$194,288
R21 · FY2011 · AT · contact PI
Progesterone Contrast Agents for MRI$188,438
R21 · FY2011 · CA
Identification of novel phytoprogestins from hops and red clover$235,500
R21 · FY2010 · AT · contact PI
Progesterone Contrast Agents for MRI$174,497
R21 · FY2010 · CA
Ovulation, inclusion cysts, and p53 mutations in a mouse model of ovarian cancer$78,500
R03 · FY2010 · CA · contact PI
Ovulation, inclusion cysts, and p53 mutations in a mouse model of ovarian cancer$78,500
R03 · FY2009 · CA · contact PI
Cimicifuga racemosa as a serotonin modulator$32,871
F31 · FY2002 · AT
Cimicifuga racemosa as a serotonin modulator$30,761
F31 · FY2001 · AT